tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TAK Stock Latest News

Takeda, Vela Transport announce medicine shipping partnership
The FlyTakeda, Vela Transport announce medicine shipping partnership
2d ago
TAK
Protagonist Therapeutics initiated with an Outperform at Leerink
PremiumThe Fly
Protagonist Therapeutics initiated with an Outperform at Leerink
6d ago
JNJ
TAK
Alkermes price target lowered to $43 from $45 at Needham
PremiumThe Fly
Alkermes price target lowered to $43 from $45 at Needham
9d ago
TAK
ALKS
Harmony Biosciences price target lowered to $48 from $49 at Needham
PremiumThe Fly
Harmony Biosciences price target lowered to $48 from $49 at Needham
9d ago
TAK
HRMY
Alkermes price target raised to $35 from $34 at JPMorgan
PremiumThe Fly
Alkermes price target raised to $35 from $34 at JPMorgan
9d ago
TAK
ALKS
Promising Phase 3 Results for Takeda’s Oveporexton Boost Buy Rating
PremiumRatingsPromising Phase 3 Results for Takeda’s Oveporexton Boost Buy Rating
9d ago
TAK
Takeda Pharmaceutical’s Promising Narcolepsy Treatment Drives Buy Rating
Premium
Ratings
Takeda Pharmaceutical’s Promising Narcolepsy Treatment Drives Buy Rating
10d ago
TAK
Jefferies says stage set for Centessa to differentiate in narcolepsy
Premium
The Fly
Jefferies says stage set for Centessa to differentiate in narcolepsy
10d ago
TAK
ALKS
Takeda reports FirstLight, RadiantLight studies met all endpoints
PremiumThe Fly
Takeda reports FirstLight, RadiantLight studies met all endpoints
10d ago
TAK
Takeda announces U.S. FDA approved the sBLA for VONVENDI
PremiumThe Fly
Takeda announces U.S. FDA approved the sBLA for VONVENDI
11d ago
TAK
Novavax’s COVID-19 vaccine Nuvaxovid approved in Japan
PremiumThe Fly
Novavax’s COVID-19 vaccine Nuvaxovid approved in Japan
14d ago
TAK
NVAX
Here’s what Wall Street experts are saying about Salesforce ahead of earnings
PremiumThe Fly
Here’s what Wall Street experts are saying about Salesforce ahead of earnings
15d ago
CRM
NOW
Alkermes initiated with an Overweight at Wells Fargo
PremiumThe FlyAlkermes initiated with an Overweight at Wells Fargo
16d ago
TAK
ALKS
Takeda’s FRUZAQLA reimbursed in Quebec for treatment of mCRC
Premium
The Fly
Takeda’s FRUZAQLA reimbursed in Quebec for treatment of mCRC
21d ago
TAK
Ionis Pharmaceuticals price target raised to $70 from $65 at H.C. Wainwright
Premium
The Fly
Ionis Pharmaceuticals price target raised to $70 from $65 at H.C. Wainwright
27d ago
TAK
IONS
Takeda Pharmaceutical Reports Q1 2025 Earnings
PremiumCompany Announcements
Takeda Pharmaceutical Reports Q1 2025 Earnings
2M ago
TAK
Takeda reports Q1 core EPS 151 yen vs. 176 yen last year
PremiumThe Fly
Takeda reports Q1 core EPS 151 yen vs. 176 yen last year
2M ago
TAK
Takeda backs FY25 core EPS view 485 yen
PremiumThe Fly
Takeda backs FY25 core EPS view 485 yen
2M ago
TAK
Alkermes selling off on limited data disclosure, says BofA
PremiumThe Fly
Alkermes selling off on limited data disclosure, says BofA
2M ago
TAK
ALKS
Takeda receives FDA clearance for HyHub, HyHub Duo
PremiumThe FlyTakeda receives FDA clearance for HyHub, HyHub Duo
2M ago
TAK
Avidity, Phathom mentioned as potential takeout targets at Needham
Premium
The Fly
Avidity, Phathom mentioned as potential takeout targets at Needham
2M ago
BMY
NVO
Keros Therapeutics announces first patient dosed in Phase 3 RENEW trial
Premium
The Fly
Keros Therapeutics announces first patient dosed in Phase 3 RENEW trial
2M ago
TAK
KROS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >